Autistic Disorder
📧 Sign up to get email alerts when something new happens for Autistic Disorder.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-10EMA Authorised: Slenyto (melatonin) — RAD Neurim Pharmaceuticals EEC SARL
Slenyto (melatonin) has been authorized for sleep initiation and maintenance disorders and autistic disorder in the EU.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD) [NA]
A clinical trial is evaluating a telehealth, parent-implemented intervention for young children with autism spectrum disorders, sponsored by…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder [NA]
The clinical trial update indicates the confirmatory efficacy trial of Cognitive Enhancement Therapy for adults with Autism Spectrum Disorde…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: 28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder [Phase 1]
Phase 1 crossover study assessing safety and tolerability of SB-121 (Lactobacillus reuteri with Sephadex and maltose) in adolescents and you…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2
A completed clinical trial evaluating low level laser light therapy for Autistic Disorder, with results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Engaging Siblings of Adults With Autism in Future Planning [NA]
Completed clinical trial studying engagement of siblings of adults with autism in future planning; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: An Evaluation of Low Level Laser Light Therapy for Autistic Disorder [NA]
A completed clinical trial evaluating low level laser light therapy for Autistic Disorder; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder [Phase 3]
Phase 3 clinical trial evaluating aripiprazole oral solution for children and adolescents with autistic disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-15Clinical Trial Update: Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder [Phase 2]
Phase 2 clinical trial investigating sulforaphane for treating autism spectrum disorders in young men; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Intranasal Dexmedetomidine vs Oral Triclofos Sodium for EEG in Children With Autism [Phase 4]
Phase 4 clinical trial comparing intranasal dexmedetomidine to oral triclofos sodium for EEG in children with autism.
-
FDA approval · 2020-02-06FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental abbreviated new drug application for aripiprazole, granting approval of a generic version.
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc., signaling an approved mod…
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-Tab (risperidone) from Janssen Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
Clinical trial update for MITA, an early intervention language training program for children with autism spectrum disorder, completed with r…
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Training Attention and Eye Movement in ASD [NA]
Clinical trial about training attention and eye movement in autism spectrum disorders has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism [Phase 2, Phase 3]
A clinical trial update reports on efficacy testing of subcutaneous methyl-B12 in children with autistic disorder, spanning Phase 2 and Phas…
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: Pivotal Response Group Treatment for Parents of Young Children With Autism [NA]
A completed clinical trial investigating pivotal response group treatment for parents of young children with autism; results posted.
-
CLINICAL_TRIALS withdrawal · 2019-04-24Clinical Trial Update: Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine [Phase 2]
Clinical trial update on a Phase 2 withdrawal study of memantine in pediatric patients with autism spectrum disorders after prior memantine …
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism [Phase 3]
Phase 3 trial evaluating aripiprazole and D-cycloserine for symptoms of autism has completed with results posted.
-
CLINICAL_TRIALS research · 2018-09-26Clinical Trial Update: Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) [Phase 4]
Phase 4 clinical trial assessing biomarkers in aripiprazole and risperidone treatment for autistic disorder (BAART) has completed with resul…
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder [Phase 3]
Phase 3 long-term extension study of aripiprazole in pediatric patients with autistic disorder; results were posted after completion in 2017…
-
CLINICAL_TRIALS trial_result · 2017-10-05Clinical Trial Update: Donepezil HCl & Cognitive Deficits in Autism [Phase 2]
Phase 2 clinical trial evaluating donepezil hydrochloride for cognitive deficits in autism has completed with results posted.
-
FDA approval · 2017-02-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for aripiprazole, enabling the generic version to be marketed.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Safety and Effectiveness of D-Cycloserine in Children With Autism [Phase 3]
Phase 3 trial evaluating safety and effectiveness of D-Cycloserine in children with autism has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) [Phase 2]
An open-label Phase 2 safety study of memantine in pediatric patients with autism spectrum disorders has completed, with results posted in 2…